BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 12269837)

  • 1. Preassembly of membrane-active peptides is an important factor in their selectivity toward target cells.
    Sal-Man N; Oren Z; Shai Y
    Biochemistry; 2002 Oct; 41(39):11921-30. PubMed ID: 12269837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action.
    Avrahami D; Shai Y
    Biochemistry; 2003 Dec; 42(50):14946-56. PubMed ID: 14674771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of a magainin analogue with lipophilic acids controls hydrophobicity, solution assembly, and cell selectivity.
    Avrahami D; Shai Y
    Biochemistry; 2002 Feb; 41(7):2254-63. PubMed ID: 11841217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of multiple aliphatic amino acids substitutions on the structure, function, and mode of action of diastereomeric membrane active peptides.
    Avrahami D; Oren Z; Shai Y
    Biochemistry; 2001 Oct; 40(42):12591-603. PubMed ID: 11601983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function.
    Oren Z; Shai Y
    Biochemistry; 2000 May; 39(20):6103-14. PubMed ID: 10821683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study on the structure and function of a cytolytic alpha-helical peptide and its antimicrobial beta-sheet diastereomer.
    Oren Z; Hong J; Shai Y
    Eur J Biochem; 1999 Jan; 259(1-2):360-9. PubMed ID: 9914515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes.
    Hong J; Oren Z; Shai Y
    Biochemistry; 1999 Dec; 38(51):16963-73. PubMed ID: 10606532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugation of fatty acids with different lengths modulates the antibacterial and antifungal activity of a cationic biologically inactive peptide.
    Malina A; Shai Y
    Biochem J; 2005 Sep; 390(Pt 3):695-702. PubMed ID: 15907192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for membrane selectivity of NK-2, a potent peptide antibiotic derived from NK-lysin.
    Schröder-Borm H; Willumeit R; Brandenburg K; Andrä J
    Biochim Biophys Acta; 2003 Jun; 1612(2):164-71. PubMed ID: 12787934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteria May Cope Differently from Similar Membrane Damage Caused by the Australian Tree Frog Antimicrobial Peptide Maculatin 1.1.
    Sani MA; Henriques ST; Weber D; Separovic F
    J Biol Chem; 2015 Aug; 290(32):19853-62. PubMed ID: 26100634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of drastic sequence alteration and D-amino acid incorporation on the membrane binding behavior of lytic peptides.
    Papo N; Shai Y
    Biochemistry; 2004 Jun; 43(21):6393-403. PubMed ID: 15157073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb.
    Jang SA; Kim H; Lee JY; Shin JR; Kim DJ; Cho JH; Kim SC
    Peptides; 2012 Apr; 34(2):283-9. PubMed ID: 22306477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective toxicity of antimicrobial peptide S-thanatin on bacteria.
    Wu G; Wu H; Fan X; Zhao R; Li X; Wang S; Ma Y; Shen Z; Xi T
    Peptides; 2010 Sep; 31(9):1669-73. PubMed ID: 20600431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane disruptive antimicrobial activities of human β-defensin-3 analogs.
    Sudheendra US; Dhople V; Datta A; Kar RK; Shelburne CE; Bhunia A; Ramamoorthy A
    Eur J Med Chem; 2015 Feb; 91():91-9. PubMed ID: 25112689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of a central proline in model amphipathic alpha-helical peptides to self-association, interaction with phospholipids, and antimicrobial mode of action.
    Yang ST; Lee JY; Kim HJ; Eu YJ; Shin SY; Hahm KS; Kim JI
    FEBS J; 2006 Sep; 273(17):4040-54. PubMed ID: 16889633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Branched phospholipids render lipid vesicles more susceptible to membrane-active peptides.
    Mitchell NJ; Seaton P; Pokorny A
    Biochim Biophys Acta; 2016 May; 1858(5):988-94. PubMed ID: 26514602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid selectivity in novel antimicrobial peptides: Implication on antimicrobial and hemolytic activity.
    Maturana P; Martinez M; Noguera ME; Santos NC; Disalvo EA; Semorile L; Maffia PC; Hollmann A
    Colloids Surf B Biointerfaces; 2017 May; 153():152-159. PubMed ID: 28236791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immobilization reduces the activity of surface-bound cationic antimicrobial peptides with no influence upon the activity spectrum.
    Bagheri M; Beyermann M; Dathe M
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1132-41. PubMed ID: 19104020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes.
    Wieprecht T; Dathe M; Beyermann M; Krause E; Maloy WL; MacDonald DL; Bienert M
    Biochemistry; 1997 May; 36(20):6124-32. PubMed ID: 9166783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activities and action mechanism studies of transportan 10 and its analogues against multidrug-resistant bacteria.
    Xie J; Gou Y; Zhao Q; Li S; Zhang W; Song J; Mou L; Li J; Wang K; Zhang B; Yang W; Wang R
    J Pept Sci; 2015 Jul; 21(7):599-607. PubMed ID: 25891396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.